GPR35 Blocking Peptide | Cayman-10007661-1 |
L-Biopterin | Cayman-10007662-10 |
L-Biopterin | Cayman-10007662-25 |
L-Biopterin | Cayman-10007662-5 |
L-Biopterin | Cayman-10007662-50 |
SREBP-2 Polyclonal Antibody | Cayman-10007663-1 |
LDL Receptor Polyclonal Antibody | Cayman-10007665-1 |
LDL Receptor Blocking Peptide | Cayman-10007672-1 |
Semi-Quantitative Biomarker EIA Component Kit (anti-mouse) | Cayman-10007680-1 |
Semi-Quantitative Biomarker EIA Component Kit (anti-mouse) | Cayman-10007680-5 |
Serum Retinol Binding Protein 4 Polyclonal Antibody | Cayman-10007681-1 |
Serum Retinol Binding Protein 4 Blocking Peptide | Cayman-10007682-1 |
Prostaglandin D Synthase (lipocalin-type; human) EIA Kit | Cayman-10007684-480 |
Prostaglandin D Synthase (lipocalin-type; human) EIA Kit | Cayman-10007684-96 |
PPARγ FP-Based Ligand Screening Assay Kit - Green | Cayman-10007685-1920 |
PPARγ FP-Based Ligand Screening Assay Kit - Green | Cayman-10007685-384 |
Acetyl Podocarpic Acid Anhydride | Cayman-10007686-1 |
Acetyl Podocarpic Acid Anhydride | Cayman-10007686-10 |
Acetyl Podocarpic Acid Anhydride | Cayman-10007686-5 |
Acetyl Podocarpic Acid Anhydride | Cayman-10007686-50 |
URB754 | Cayman-10007691-10 |
URB754 | Cayman-10007691-25 |
URB754 | Cayman-10007691-5 |
URB754 | Cayman-10007691-50 |
Licofelone | Cayman-10007692-1 |
Licofelone | Cayman-10007692-10 |
Licofelone | Cayman-10007692-5 |
Licofelone | Cayman-10007692-50 |
N-Palmitoyl Dopamine | Cayman-10007697-10 |
N-Palmitoyl Dopamine | Cayman-10007697-100 |
N-Palmitoyl Dopamine | Cayman-10007697-5 |
N-Palmitoyl Dopamine | Cayman-10007697-50 |
N-(3-hydroxyphenyl)-Arachidonoyl amide | Cayman-10007704-10 |
N-(3-hydroxyphenyl)-Arachidonoyl amide | Cayman-10007704-100 |
N-(3-hydroxyphenyl)-Arachidonoyl amide | Cayman-10007704-5 |
N-(3-hydroxyphenyl)-Arachidonoyl amide | Cayman-10007704-50 |
α-CEHC | Cayman-10007705-1 |
α-CEHC | Cayman-10007705-10 |
α-CEHC | Cayman-10007705-25 |
α-CEHC | Cayman-10007705-5 |
δ-CEHC | Cayman-10007706-1 |
δ-CEHC | Cayman-10007706-10 |
δ-CEHC | Cayman-10007706-25 |
δ-CEHC | Cayman-10007706-5 |
AS-605240 | Cayman-10007707-1 |
AS-605240 | Cayman-10007707-10 |
AS-605240 | Cayman-10007707-5 |
AS-605240 | Cayman-10007707-50 |
PtdIns-(1,2-dipalmitoyl) (ammonium salt) | Cayman-10007710-0.1 |
PtdIns-(1,2-dipalmitoyl) (ammonium salt) | Cayman-10007710-0.5 |
PtdIns-(1,2-dipalmitoyl) (ammonium salt) | Cayman-10007710-1 |
PtdIns-(1,2-dipalmitoyl) (ammonium salt) | Cayman-10007710-5 |
PtdIns-(4)-P1 (1,2-dioctanoyl) (ammonium salt) | Cayman-10007711-0.1 |
PtdIns-(4)-P1 (1,2-dioctanoyl) (ammonium salt) | Cayman-10007711-0.5 |
PtdIns-(4)-P1 (1,2-dioctanoyl) (ammonium salt) | Cayman-10007711-1 |
PtdIns-(4)-P1 (1,2-dioctanoyl) (ammonium salt) | Cayman-10007711-5 |
HMB-Val-Ser-Leu-VE | Cayman-10007713-1 |
HMB-Val-Ser-Leu-VE | Cayman-10007713-10 |
HMB-Val-Ser-Leu-VE | Cayman-10007713-25 |
HMB-Val-Ser-Leu-VE | Cayman-10007713-5 |
5(S),6(R)-Lipoxin A4-d5 | Cayman-10007737-10 |
5(S),6(R)-Lipoxin A4-d5 | Cayman-10007737-100 |
5(S),6(R)-Lipoxin A4-d5 | Cayman-10007737-25 |
5(S),6(R)-Lipoxin A4-d5 | Cayman-10007737-50 |
N-Cyclohexanecarbonylpentadecylamine | Cayman-10007739-10 |
N-Cyclohexanecarbonylpentadecylamine | Cayman-10007739-100 |
N-Cyclohexanecarbonylpentadecylamine | Cayman-10007739-5 |
N-Cyclohexanecarbonylpentadecylamine | Cayman-10007739-50 |
PtdIns-(4)-P1 (1,2-dihexanoyl) (sodium salt) | Cayman-10007757-0.1 |
PtdIns-(4)-P1 (1,2-dihexanoyl) (sodium salt) | Cayman-10007757-0.5 |
PtdIns-(4)-P1 (1,2-dihexanoyl) (sodium salt) | Cayman-10007757-1 |
PtdIns-(4)-P1 (1,2-dihexanoyl) (sodium salt) | Cayman-10007757-5 |
PtdIns-(5)-P1 (1,2-dioctanoyl) (ammonium salt) | Cayman-10007758-0.1 |
PtdIns-(5)-P1 (1,2-dioctanoyl) (ammonium salt) | Cayman-10007758-0.5 |
PtdIns-(5)-P1 (1,2-dioctanoyl) (ammonium salt) | Cayman-10007758-1 |
PtdIns-(5)-P1 (1,2-dioctanoyl) (ammonium salt) | Cayman-10007758-5 |
PtdIns-(3,4)-P2 (1,2-dihexanoyl) (sodium salt) | Cayman-10007759-0.1 |
PtdIns-(3,4)-P2 (1,2-dihexanoyl) (sodium salt) | Cayman-10007759-0.5 |
PtdIns-(3,4)-P2 (1,2-dihexanoyl) (sodium salt) | Cayman-10007759-1 |
PtdIns-(3,4)-P2 (1,2-dihexanoyl) (sodium salt) | Cayman-10007759-5 |
PtdIns-(4,5)-P2 (1,2-dihexanoyl) (sodium salt) | Cayman-10007762-0.1 |
PtdIns-(4,5)-P2 (1,2-dihexanoyl) (sodium salt) | Cayman-10007762-0.5 |
PtdIns-(4,5)-P2 (1,2-dihexanoyl) (sodium salt) | Cayman-10007762-1 |
PtdIns-(4,5)-P2 (1,2-dihexanoyl) (sodium salt) | Cayman-10007762-5 |
PtdIns-(3,5)-P2 (1,2-dioctanoyl) (sodium salt) | Cayman-10007763-0.1 |
PtdIns-(3,5)-P2 (1,2-dioctanoyl) (sodium salt) | Cayman-10007763-0.5 |
PtdIns-(3,5)-P2 (1,2-dioctanoyl) (sodium salt) | Cayman-10007763-1 |
PtdIns-(3,5)-P2 (1,2-dioctanoyl) (sodium salt) | Cayman-10007763-5 |
PtdIns-(3,4,5)-P3 (1,2-dioctanoyl) (sodium salt) | Cayman-10007764-0.1 |
PtdIns-(3,4,5)-P3 (1,2-dioctanoyl) (sodium salt) | Cayman-10007764-0.5 |
PtdIns-(3,4,5)-P3 (1,2-dioctanoyl) (sodium salt) | Cayman-10007764-1 |
PtdIns-(3,4,5)-P3 (1,2-dioctanoyl) (sodium salt) | Cayman-10007764-5 |
19(R)-HETE | Cayman-10007767-100 |
19(R)-HETE | Cayman-10007767-25 |
19(R)-HETE | Cayman-10007767-50 |
19(R)-HETE | Cayman-10007767-500 |
D-myo-Inositol-1-phosphate (sodium salt) | Cayman-10007777-0.5 |
D-myo-Inositol-1-phosphate (sodium salt) | Cayman-10007777-1 |
D-myo-Inositol-1-phosphate (sodium salt) | Cayman-10007777-10 |